PMID- 11514583 OWN - NLM STAT- MEDLINE DCOM- 20011207 LR - 20220408 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 276 IP - 43 DP - 2001 Oct 26 TI - Regulation of the hypoxia-inducible factor 1alpha by the inflammatory mediators nitric oxide and tumor necrosis factor-alpha in contrast to desferroxamine and phenylarsine oxide. PG - 39805-11 AB - Hypoxic/ischemic conditions provoke activation of the hypoxia-inducible factor-1 (HIF-1), which functions as a transcription factor. HIF-1 is composed of the HIF-1alpha and -beta subunits, and stability regulation occurs via accumulation/degradation of HIF-1alpha with the notion that a prolyl hydroxylase accounts for changes in protein level. In addition, there is evidence that HIF-1 is up-regulated by diverse agonists during normoxia. We investigated the impact of inflammatory mediators nitric oxide (NO) and tumor necrosis factor-alpha (TNF-alpha) on HIF-1alpha regulation. For comparison, LLC-PK(1) cells were exposed to hypoxia, stimulated with desferroxamine (DFX, known to mimic hypoxia), and the thiol-cross-linking agent phenylarsine oxide (PAO). Although all stimuli elicited HIF-1alpha stabilization with differences in the time-dependent accumulation pattern, significant variations appeared with regard to signaling. With the use of a superoxide anion (O(2-)) generator, we established an O(2-)-sensitive pathway that blocked HIF-1alpha stabilization in response to NO and TNF-alpha while DFX- and PAO-evoked HIF-1alpha stabilization appeared O(2-)-insensitive. NO and TNF-alpha signaling required phosphorylation events, especially activation of the phosphatidylinositol 3-kinase/Akt, which is in contrast to DFX and PAO. Based on HIF-1-dependent luciferase reporter gene analysis, it was found that, in contrast to NO and TNF-alpha, PAO resembled a stimulus that induced a dysfunctional HIF-1 complex. These data indicate that diverse agonists activate HIF-1alpha under normoxic conditions by employing different signaling pathways. FAU - Sandau, K B AU - Sandau KB AD - Faculty of Biology, University of Kaiserslautern, Erwin-Schrodinger-Strasse, 67663 Kaiserslautern, Germany. FAU - Zhou, J AU - Zhou J FAU - Kietzmann, T AU - Kietzmann T FAU - Brune, B AU - Brune B LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20010820 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Androstadienes) RN - 0 (Arsenicals) RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) RN - 0 (Inflammation Mediators) RN - 0 (Protein Subunits) RN - 0 (Proto-Oncogene Proteins) RN - 0 (Reactive Oxygen Species) RN - 0 (Transcription Factors) RN - 0 (Tumor Necrosis Factor-alpha) RN - 0HUR2WY345 (oxophenylarsine) RN - 31C4KY9ESH (Nitric Oxide) RN - DH2M523P0H (Genistein) RN - EC 2.7.11.1 (Protein Serine-Threonine Kinases) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - J06Y7MXW4D (Deferoxamine) RN - S88TT14065 (Oxygen) RN - XVA4O219QW (Wortmannin) SB - IM MH - Androstadienes/pharmacology MH - Arsenicals/*pharmacology MH - Deferoxamine/*pharmacology MH - Genistein/pharmacology MH - Hypoxia-Inducible Factor 1, alpha Subunit MH - Inflammation Mediators/*pharmacology MH - Kidney/blood supply MH - Kidney Tubules, Proximal/cytology/metabolism MH - Nitric Oxide/*pharmacology MH - Oxygen/pharmacology MH - Phosphorylation MH - *Protein Serine-Threonine Kinases MH - Protein Subunits MH - Proto-Oncogene Proteins/metabolism MH - Proto-Oncogene Proteins c-akt MH - Reactive Oxygen Species MH - Reperfusion Injury MH - Signal Transduction MH - Transcription Factors/*biosynthesis MH - Tumor Necrosis Factor-alpha/*pharmacology MH - Up-Regulation MH - Wortmannin EDAT- 2001/08/22 10:00 MHDA- 2002/01/05 10:01 CRDT- 2001/08/22 10:00 PHST- 2001/08/22 10:00 [pubmed] PHST- 2002/01/05 10:01 [medline] PHST- 2001/08/22 10:00 [entrez] AID - S0021-9258(20)60045-X [pii] AID - 10.1074/jbc.M107689200 [doi] PST - ppublish SO - J Biol Chem. 2001 Oct 26;276(43):39805-11. doi: 10.1074/jbc.M107689200. Epub 2001 Aug 20.